CIK 0001447028 · Non-accelerated filer<br>Smaller reporting company
Arbutus Biopharma Corp
Sign in to watch- Ticker
- ABUS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- EIN
- 980597776
- Phone
- 604-419-3200
- Business address
- 701 VETERANS CIRCLE, WARMINSTER, PA, 18974
- Former names
- TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-18 | Beardsley Robert A Director | Option exercise | +52,533 | $3.20 | $168K | 52,533 |
| 2026-09-18 | Beardsley Robert A Director | Option exercise | +78,800 | $4.24 | $334K | 131,333 |
| 2026-09-18 | Beardsley Robert A Director | Shares withheld for taxes | −99,057 | $5.07 | $502K | 32,276 |
| 2026-09-18 | Beardsley Robert A Director | Option exercise · Stock Option (Right to Buy) | −52,533 | 105,067 | ||
| 2026-09-18 | Beardsley Robert A Director | Option exercise · Stock Option (Right to Buy) | −78,800 | 0 | ||
| 2026-06-08 | Sawhney Roger Director | Grant or award · Stock Option (Right to Buy) | +78,800 | 78,800 | ||
| 2026-06-08 | Beardsley Robert A Director | Grant or award · Stock Option (Right to Buy) | +78,800 | 78,800 | ||
| 2026-02-02 | Nguyen Tuan Chief Financial Officer | Grant or award | +73,500 | 73,500 | ||
| 2026-02-02 | Nguyen Tuan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +188,400 | 188,400 | ||
| 2026-02-02 | Androski Lindsay President and CEO | Grant or award | +28,000 | 28,000 | ||
| 2026-02-02 | Androski Lindsay President and CEO | Grant or award · Stock Option (Right to Buy) | +71,700 | 71,700 | ||
| 2025-08-04 | Sawhney Roger Director | Grant or award · Stock Option (Right to Buy) | +157,600 | 157,600 | ||
| 2025-03-31 | Nguyen Tuan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +750,000 | 750,000 | ||
| 2025-03-31 | Nguyen Tuan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +750,000 | 750,000 | ||
| 2025-03-18 | Hasija Anuj Director | Grant or award · Stock Option (Right to Buy) | +157,600 | 157,600 | ||
| 2025-03-18 | Beardsley Robert A Director | Grant or award · Stock Option (Right to Buy) | +157,600 | 157,600 | ||
| 2025-03-18 | Androski Lindsay President and CEO | Grant or award · Stock Option (Right to Buy) | +310,422 | 310,422 | ||
| 2025-02-14 | Naftzger J. Christopher General Counsel and CCO | Grant or award | +54,300 | 140,544 | ||
| 2025-02-14 | Naftzger J. Christopher General Counsel and CCO | Grant or award · Stock Option (Right to Buy) | +220,300 | 220,300 | ||
| 2025-02-14 | McElhaugh Michael J. Interim President & CEO | Grant or award | +177,000 | 1,658,003 |
Page 2 of 8 · 141 trades